Use of Cardiac-MRI to Predict Results for People With Severe Aortic Stenosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2013-06-27

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

\- Aortic valve stenosis is a disease that makes a major heart valve get smaller. This reduces heart function and causes death. Severe aortic stenosis (AS) can be treated in a couple of ways, including replacing a heart valve.

Objectives:

Researchers want to study fibrosis in the heart. A sub-study will test whether heart function and blood supply improve after a valve replacement.

Eligibility:

\- Adults at least 18 years old with aortic stenosis.

Design:

* Participants will visit a clinic for 1 day for magnetic resonance imaging (MRI) of their heart. This uses magnets, radio waves, and computers to produce detailed pictures of the heart.
* After this visit, participants will have their aortic valve procedure at the the Washington Hospital Center. A hospital team will contact participants for 1 year by phone or email. This follow-up will consist of 15 minutes of questions about the participant s health status.
* Some participants will join a sub-study.
* They will be given an additional medication to evaluate the blood supply of the heart.
* They will visit a clinic for 1 day for an MRI of their heart, as part of the main study, prior to the aortic valve replacement.
* After they have their valve replaced at the hospital, they will return to the clinic for another MRI.
* They will have the same follow-up as in the main study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cardiac MRI for Severe Aortic Stenosis

NCT01638156

Aortic Stenosis

COMPLETED

Biomarkers and Mechanisms of Disease Progression and Outcome of Aortic Stenosis in Humans

NCT05851209

Aortic Stenosis Imaging Pathogenesis +3 more

NOT_YET_RECRUITING

Valvular Aortic Stenosis: Study of Myocardiac Fibrosis by Magnetic Resonance Imagery

NCT02551588

Aortic Valve Stenosis

COMPLETED

Positron Emission Tomography / Magnetic Resonance Imaging in Aortic Stenosis

NCT03352089

Aortic Stenosis Transthyretin Amyloidosis

COMPLETED

A Comparison of Advanced Imaging Techniques in Aortic Stenosis

NCT01775215

Aortic Stenosis

WITHDRAWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aortic valve stenosis is a disease that causes narrowing of a major heart valve, and that reduces heart function and causes death. The purpose of this protocol is to use magnetic resonance imaging of the heart to identify which patients would benefit from replacement of the diseased valve.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Severe aortic stenosis defined as aortic valve area of less than 1 cm(2) or index area of 0.6 cm(2)/m(2) by echocardiography.
2. Symptomatic patients with aortic stenosis referred for medically indicated AVR
3. LV EF less than or equal to 0.50
4. Signed informed consent to participate in the study.

Specific criteria for MR perfusion sub-study:
5. Absence of any significant coronary lesions or presence of coronary disease for conservative (medical) therapy\<TAB\>.

Exclusion Criteria

1. Inability to sign written informed consent.
2. Subjects with contraindication to MRI scanning, including the following devices or conditions:

* Cardiac pacemaker or implantable defibrillator
* Cerebral aneurysm clip
* Neural stimulator (e.g. TENS-Unit)
* Any type of ear implant
* Ocular foreign body (e.g. metal shavings)
* Any implanted device (e.g. insulin pump, drug infusion device)
* Metal shrapnel or bullet.
* Atrial fibrillation
3. Subjects with a known hypersensitivity, allergy or contraindication to iodine or gadolinium
4. Impaired renal excretory function, calculated as Glomerular Filtration Rate (GFR) \<30mL/min/1.73m(2).
5. Contraindications for intravenous adenosine infusion:

* Known hypersensitivity to adenosine
* Known or suspected significant bronchoconstrictive or bronchospastic disease
* 2nd or 3rd degree atrioventricular (AV) block unless with permanent pacemaker
* Sinus bradycardia (heart rate \< 45 bpm) unless with permanent pacemaker
* Systemic arterial hypotension (\< 90 mmHg)
6. Presence of any coexisting severe valvular disorder.
7. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).
8. Need for emergency surgery for any reason.
9. Any case in which the practicing physician asserts that enrollment in the protocol will adversely affect the patient treatment course.

No detectable reversible ischemia on pre-treatment/procedure cardiac MRI.

Subject underwent transcatheter AVR as part of one of the transcatheter heart valve trials (i.e. PARTNER trial or the pivotal CoreValve trial).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No